In heart failure (HF), acute decompensation can occur quickly and unexpectedly because of
worsening of chronic HF or to new‐onset HF diagnosed for the first time ('de novo'). Patients …

Heart failure (HF) is an important cardiovascular disease because of its increasing
prevalence, significant morbidity, high mortality, and rapidly expanding health care cost. The …

Acute heart failure (AHF) has become a global public health burden largely because of the
associated high morbidity, mortality, and cost. The treatment options for AHF have remained …

Aim Acute heart failure can be a life‐threatening medical condition. Delaying administration
of intravenous furosemide (time‐to‐diuretics) has been postulated to increase mortality, but …

Most episodes of acute heart failure (AHF) are characterized by increasing signs and
symptoms of congestion, manifested by edema, pleura effusion and/or ascites. Immediately …

Heart failure (HF) is a progressive condition with intermittent acute decompensation leading
to poor prognosis despite established guideline-directed therapy. A paradigm of HF therapy …

Door-to-furosemide time and clinical outcomes in acute heart... : European Journal of
Emergency Medicine Door-to-furosemide time and clinical outcomes in acute heart failure …

Aim To illustrate the pre‐hospital management arsenals and protocols in different EMS units,
and to estimate the perceived difficulty of diagnosing suspected acute heart failure (AHF) …

Aims Treating patients with acute decompensated heart failure (ADHF) presenting with
volume overload is a common task. However, optimal guidance of decongesting therapy …

HIGHLIGHTS•Prompt initiation of diuretic therapy was not correlated with faster
decongestion in acute heart failure.•The timing of decongestion but not diuretics was …